BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29625688)

  • 1. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS.
    Chiu HH; Liao HW; Shao YY; Lu YS; Lin CH; Tsai IL; Kuo CH
    Anal Chim Acta; 2018 Aug; 1019():93-102. PubMed ID: 29625688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma.
    Chiu HH; Tsai IL; Lu YS; Lin CH; Kuo CH
    Anal Bioanal Chem; 2017 Nov; 409(28):6583-6593. PubMed ID: 28963670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion.
    Chiu HH; Tsai YJ; Lo C; Lin CH; Tsai IL; Kuo CH
    Anal Chim Acta; 2022 Feb; 1193():339319. PubMed ID: 35058007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
    Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
    Willeman T; Jourdil JF; Gautier-Veyret E; Bonaz B; Stanke-Labesque F
    Anal Chim Acta; 2019 Aug; 1067():63-70. PubMed ID: 31047150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies.
    Li H; Ortiz R; Tran L; Hall M; Spahr C; Walker K; Laudemann J; Miller S; Salimi-Moosavi H; Lee JW
    Anal Chem; 2012 Feb; 84(3):1267-73. PubMed ID: 22243404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an LC-MS/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples.
    Chiu HH; Tsai YJ; Lo C; Liao HW; Lin CH; Tang SC; Kuo CH
    Anal Chim Acta; 2022 Jan; 1189():339231. PubMed ID: 34815034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory universal LC-MS/MS assay for bioanalysis of hinge region-stabilized human IgG4 mAbs in clinical studies.
    Furlong MT; Titsch C; Xu W; Jiang H; Jemal M; Zeng J
    Bioanalysis; 2014; 6(13):1747-58. PubMed ID: 24661028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the utility of minimized sample preparation and high-resolution mass spectrometry for quantification of monoclonal antibody drugs.
    Nguyen TTTN; Mistarz UH; Costa N; Herbet A; Boquet D; Becher F; Rand KD
    J Pharm Biomed Anal; 2018 Sep; 159():384-392. PubMed ID: 30071466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flexibility of a generic LC-MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies.
    Lanshoeft C; Wolf T; Walles M; Barteau S; Picard F; Kretz O; Cianférani S; Heudi O
    J Pharm Biomed Anal; 2016 Nov; 131():214-222. PubMed ID: 27599352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry.
    Amrani ME; Gerencser L; Huitema ADR; Hack CE; van Luin M; van der Elst KCM
    J Chromatogr A; 2021 Oct; 1655():462489. PubMed ID: 34509691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA.
    Millet A; Khoudour N; Bros P; Lebert D; Picard G; Machon C; Goldwasser F; Blanchet B; Guitton J
    Talanta; 2021 Mar; 224():121889. PubMed ID: 33379098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum.
    Jiang H; Zeng J; Titsch C; Voronin K; Akinsanya B; Luo L; Shen H; Desai DD; Allentoff A; Aubry AF; Desilva BS; Arnold ME
    Anal Chem; 2013 Oct; 85(20):9859-67. PubMed ID: 24024648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated LC-MS/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction.
    Li W; Huang W; Yu X; Chen C; Yuan Y; Liu D; Wang F; Yu J; Diao X
    J Pharm Biomed Anal; 2024 Jun; 243():116083. PubMed ID: 38447348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development.
    Osaki F; Tabata K; Oe T
    Anal Bioanal Chem; 2017 Sep; 409(23):5523-5532. PubMed ID: 28710515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
    Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
    J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.